Trump 2019: Three Things To Expect in Health Care
Client Alert | less than 1 min read | 12.12.18
As part of our Trump 2019: What To Expect series, Traci Vitek, senior policy director with the firm, and Jerrica Mathis, director in Crowell & Moring’s Government Affairs Group, sit down to discuss what we can expect Congress and the White House to focus on in 2019 regarding health care.
Discussed in this 24-minute podcast:
- Health care plans and how they are marketed.
- Drug pricing proposals.
- Congressional oversight.
Click below to listen or access from one of these links:
PodBean | SoundCloud | iTunes
Insights
Client Alert | 3 min read | 07.10.26
In Utech, Inc. v. United States, No. 24-1586 (Fed. Cir. June 24, 2026), the U.S. Court of Appeals for the Federal Circuit clarified that in most cases, a pre-award protest must be filed before the proposal submission deadline to avoid the Blue & Gold waiver rule. This decision, while nonprecedential, is in line with U.S. Government Accountability Office (GAO) precedent, which has long held that pre-award protests must be filed before the proposal submission deadline.
Client Alert | 5 min read | 07.10.26
Client Alert | 6 min read | 07.09.26
EU Steel Overcapacity Regulation: New Permanent Measure in Force from 1 July 2026
Client Alert | 5 min read | 07.09.26
Made in the USA? Prove It: FTC Marks America's 250th with Crack Down on Domestic Origin Claims
